Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics
A. Lipton, K. Fizazi, A. T. Stopeck, D. H. Henry, M. R. Smith, N. Shore, M. Martin, S. Vadhan-Raj, J. E. Brown, G. E. Richardson, F. Saad, D. A. Yardley, K. Zhou, A. Balakumaran, A. Braun
Dive into the research topics of 'Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics'. Together they form a unique fingerprint.